Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost–effectiveness and cost–utility analyses

心肌梗塞 医学 成本-效用分析 重症监护医学 经济 成本效益 心脏病学 风险分析(工程)
作者
Isabelle Durand‐Zaleski,Grégory Ducrocq,Maroua Mimouni,J. Frenkiel,C. Avendaño,José Ramón González‐Juanatey,Émile Ferrari,Gilles Lemesle,Étienne Puymirat,Laurence Berard,Marine Cachanado,Joan Albert Arnáiz,Manuel Martínez‐Sellés,Johanne Silvain,Albert Ariza‐Solé,Gonzalo Calvo,Nicolas Danchin,Sandra Paco,Élodie Drouet,Hélène Abergel
出处
期刊:European Heart Journal - Quality of Care and Clinical Outcomes [Oxford University Press]
卷期号:9 (2): 194-202 被引量:14
标识
DOI:10.1093/ehjqcco/qcac029
摘要

AIMS: To estimate the cost-effectiveness and cost-utility ratios of a restrictive vs. liberal transfusion strategy in acute myocardial infarction (AMI) patients with anaemia. METHODS AND RESULTS: Patients (n = 666) with AMI and haemoglobin between 7-8 and 10 g/dL recruited in 35 hospitals in France and Spain were randomly assigned to a restrictive (n = 342) or a liberal (n = 324) transfusion strategy with 1-year prospective collection of resource utilization and quality of life using the EQ5D3L questionnaire. The economic evaluation was based on 648 patients from the per-protocol population. The outcomes were 30-day and 1-year cost-effectiveness, with major adverse cardiovascular events (MACEs) averted as the effectiveness outcome. and a 1-year cost-utility ratio.The 30-day incremental cost-effectiveness ratio was €33 065 saved per additional MACE averted with the restrictive vs. liberal strategy, with an 84% probability for the restrictive strategy to be cost-saving and MACE-reducing (i.e. dominant). At 1 year, the point estimate of the cost-utility ratio was €191 500 saved per quality-adjusted life year gained; however, the cumulated MACE was outside the pre-specified non-inferiority margin, resulting in a decremental cost-effectiveness ratio with a point estimate of €72 000 saved per additional MACE with the restrictive strategy. CONCLUSION: In patients with AMI and anaemia, the restrictive transfusion strategy was dominant (cost-saving and outcome-improving) at 30 days. At 1 year, the restrictive strategy remained cost-saving, but clinical non-inferiority on MACE was no longer maintained. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02648113. ONE SENTENCE SUMMARY: The use of a restrictive transfusion strategy in patients with acute myocardial infarction is associated with lower healthcare costs, but more evidence is needed to ascertain its long-term clinical impact.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Yannn完成签到,获得积分10
刚刚
苹果思天发布了新的文献求助10
1秒前
郑一鸣完成签到,获得积分10
1秒前
顺心的宛海完成签到,获得积分10
1秒前
喜洋洋完成签到 ,获得积分10
1秒前
1秒前
1秒前
2秒前
852的应助被刘小芬采纳,获得10
3秒前
3秒前
4秒前
暮色将至完成签到,获得积分20
4秒前
咖喱爆炒鱼蛋完成签到,获得积分10
4秒前
情怀的应助被开放的水壶采纳,获得10
4秒前
科研蛀虫完成签到,获得积分10
5秒前
huangyuhang完成签到,获得积分10
5秒前
RC完成签到 ,获得积分10
5秒前
苹果思天发布了新的文献求助10
6秒前
Jasper的应助被英勇啤酒人采纳,获得20
6秒前
6秒前
6秒前
Zephyrine完成签到 ,获得积分10
7秒前
星辰大海的应助被是寄竹吖采纳,获得10
7秒前
苹果思天发布了新的文献求助10
8秒前
十八与雨发布了新的文献求助50
9秒前
9秒前
苹果思天发布了新的文献求助10
10秒前
11秒前
小情绪发布了新的文献求助10
11秒前
大知闲闲发布了新的文献求助10
12秒前
苹果思天发布了新的文献求助10
13秒前
乐乐的应助被典雅的羿采纳,获得10
13秒前
dde发布了新的文献求助10
14秒前
14秒前
包包糖在摸鱼完成签到 ,获得积分10
15秒前
15秒前
15秒前
苹果思天发布了新的文献求助10
15秒前
wangwei完成签到 ,获得积分10
15秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186629
求助须知:如何正确求助?哪些是违规求助? 9574913
关于积分的说明 21838832
捐赠科研通 7784206
什么是DOI,文献DOI怎么找? 3434808
关于科研通互助平台的介绍 2559183
邀请新用户注册赠送积分活动 2481582